These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 14958642)

  • 21. [Para-aminosalicylic acid and streptomycin blood level in renal tuberculosis].
    HOESS H; LAUENER H; SCHONHOLZER G
    Urol Int; 1956; 3(2-3):114-21. PubMed ID: 13401594
    [No Abstract]   [Full Text] [Related]  

  • 22. [Results of PAS therapy in ambulatory conditions].
    ROZENSHTEIN AV
    Probl Tuberk; 1952; 1():69-70. PubMed ID: 14911778
    [No Abstract]   [Full Text] [Related]  

  • 23. [Present state of PAS therapy of tuberculous infections].
    PESCETTI G
    Gazz Med Ital; 1951 Sep; 110(9):274-6. PubMed ID: 14879905
    [No Abstract]   [Full Text] [Related]  

  • 24. [Therapeutic value of the addition of sodium benzoate to PAS in the treatment of tuberculosis; preliminary note].
    PARAF J; DESBORDES J; ROSENBERG E
    Bull Mem Soc Med Hop Paris; 1952 Jul 4-11; 68(24-25):912-4. PubMed ID: 12988032
    [No Abstract]   [Full Text] [Related]  

  • 25. [Combination treatment of tuberculosis; PAS-isoniazid perfusions].
    FREOUR P; DUPUY JK; LABROUSSE ; MAREE
    J Med Bord; 1953 Jun; 130(6):794-803. PubMed ID: 13096984
    [No Abstract]   [Full Text] [Related]  

  • 26. [Importance of determination of PAS in blood and body fluids of the patient during anti-tuberculosis therapy; causes of error].
    PARAF J; DESBORDES J; ZIVY P; PARAF M; PERETZ E
    Therapie; 1952; 7(5):400-7. PubMed ID: 13049230
    [No Abstract]   [Full Text] [Related]  

  • 27. [Tuberculostatic INHA-PAS in clinical examination].
    FRANK F; ROBEL G
    Praxis; 1954 Dec; 43(52):1100-2. PubMed ID: 13236889
    [No Abstract]   [Full Text] [Related]  

  • 28. [Isoniazide-streptomycin and isoniazide-PAS combination in the treatment of tuberculosis].
    PIECHAUD F; FREOUR P; LABROUSSE P
    J Med Bord; 1953 Jun; 130(6):849-51. PubMed ID: 13096998
    [No Abstract]   [Full Text] [Related]  

  • 29. [PAS blood content after peroral intake of different calcium-PAS-granulates].
    SANZ MC; MULLER A
    Schweiz Med Wochenschr; 1952 Dec; 82(52):1334-5. PubMed ID: 13028219
    [No Abstract]   [Full Text] [Related]  

  • 30. [Antioxygens and tuberculosis: mechanism of the action of PAS, TB 1 and isonicotinic acid hydrazide].
    BERGEL M
    Sem Med; 1952 Jul; 101(4):130-6. PubMed ID: 12995059
    [No Abstract]   [Full Text] [Related]  

  • 31. The folate pathway is a target for resistance to the drug para-aminosalicylic acid (PAS) in mycobacteria.
    Rengarajan J; Sassetti CM; Naroditskaya V; Sloutsky A; Bloom BR; Rubin EJ
    Mol Microbiol; 2004 Jul; 53(1):275-82. PubMed ID: 15225321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effectivity of combined isoniazid-PAS preparations].
    BUNGER P; SCHUTZE G
    Tuberkulosearzt; 1955 Oct; 9(10):581-7. PubMed ID: 13291486
    [No Abstract]   [Full Text] [Related]  

  • 33. Studies of conjugated PAS and ascorbic acid and other forms of para-aminosalicylic acid. I. Patient tolerance.
    DONNERBERG RL; BROWNING RH; ATWELL RJ
    Am Rev Tuberc; 1957 Nov; 76(5):877-9. PubMed ID: 13478843
    [No Abstract]   [Full Text] [Related]  

  • 34. [Side effects of PAS].
    Tidsskr Nor Laegeforen; 1951 Dec; 71(23):766-7. PubMed ID: 14922389
    [No Abstract]   [Full Text] [Related]  

  • 35. [Subcutaneous injection of PAS in the presence of a factor of diffusion].
    PARAF J; DESBORDES J; ROSENBERG E; ZIVY P; PARAF M; BORY J
    Presse Med (1893); 1952 Apr; 60(22):474-5. PubMed ID: 14948888
    [No Abstract]   [Full Text] [Related]  

  • 36. [Abuse of streptomycin, PAS and thiosemicarbazone].
    VERSTRAETEN A
    Acta Tuberc Belg; 1951 Oct; 42(5):455-61. PubMed ID: 14894323
    [No Abstract]   [Full Text] [Related]  

  • 37. [Streptomycin, PAS and rimifon].
    TREMBLAY JN
    Union Med Can; 1952 Jul; 81(7):832-7. PubMed ID: 13005823
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical and bacterial resistance during treatment of tuberculosis with streptomycin, PAS, TB 1 and INH].
    DISSMANN E
    Tuberkulosearzt; 1953 Apr; 7(4):205-14. PubMed ID: 13090321
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pharmacoplasma (PAS-plasma) transfusion and immune body formation. XV].
    BUCHER R
    Schweiz Med Wochenschr; 1951 Sep; 81(36):858-9. PubMed ID: 14883828
    [No Abstract]   [Full Text] [Related]  

  • 40. PARA-AMINOSALICYLIC acid (PAS) and streptomycin in pulmonary tuberculosis; comparison between 84 PAS-treated and 82 streptomycin-treated cases.
    Acta Tuberc Scand; 1952; 27(3-5):157-75. PubMed ID: 13040105
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.